Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech)
Dermatol Ther
.
2022 Dec;35(12):e15915.
doi: 10.1111/dth.15915.
Epub 2022 Oct 17.
Authors
Min Jae Kim
1
,
Jee Woo Kim
1
,
Jung-Im Na
1
Affiliation
1
Department of Dermatology, Seoul National University, Bundang Hospital, Seongnam, Republic of Korea.
PMID:
36209375
PMCID:
PMC9874510
DOI:
10.1111/dth.15915
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
SARS-CoV-2
Sweet Syndrome* / diagnosis
Sweet Syndrome* / etiology
Substances
COVID-19 Vaccines